OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ASIP56

AsiaPhos Ltd

Agricultural ChemicalsVerified

AsiaPhos Ltd has a highly leveraged capital structure, with a debt-to-equity ratio of 1.64, indicating that the company is financed more by debt than equity. The company's liquidity position is medium, with a current ratio of 1.07, suggesting that it has just enough current assets to cover its current liabilities. The company's operating cash flow is negative at -236,000 SGD, and its free cash flow is also negative at -415,000 SGD, indicating that it is not generating sufficient cash from operations to fund its activities. In terms of profitability, AsiaPhos Ltd is currently unprofitable, with a net income of -447,000 SGD and an operating income of -409,000 SGD. The company's return on equity is -23.35%, and its return on assets is -1.56%, both of which are significantly below the industry median for Agricultural Chemicals. The company's gross profit of 50,000 SGD is also low relative to its revenue of 260,000 SGD, indicating that it is not effectively managing its production costs. AsiaPhos Ltd's revenue is not segmented by geographic region or product line in the available data, so it is not possible to assess the company's geographic exposure or revenue concentration. However, the company's operations are likely concentrated in the agricultural chemicals sector, which is subject to fluctuations in commodity prices and demand for agricultural products. The company's growth trajectory is currently negative, with a net income of -447,000 SGD and an operating income of -409,000 SGD. There is no indication of a positive revenue growth rate in the available data, and the company's capital expenditure is zero, suggesting that it is not investing in new projects or expansion. AsiaPhos Ltd faces several risk factors, including a high debt-to-equity ratio and negative operating and free cash flows. The company's liquidity risk is medium, and its net cash position is negative after subtracting total debt, which could limit its ability to meet short-term obligations. The company's dilution risk is low, and there is no indication of recent share issuance or dilution pressure. There are no recent events or filings mentioned in the available data that would indicate significant changes in the company's operations or financial position. The company's financial performance and risk profile suggest that it is currently facing significant challenges and may require restructuring or additional financing to improve its financial health.

30-day price · ASIP+0.00 (+12.5%)
Low$0.01High$0.01Close$0.01As of19 May, 00:00 UTC
Profile
CompanyAsiaPhos Ltd
TickerASIP.SI
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. AsiaPhos Ltd is a chemical company that operates in the agricultural chemicals industry, primarily generating revenue through the production and sale of chemical products used in agriculture.

Classification. AsiaPhos Ltd is classified under the Basic Materials economic sector, within the Chemicals business sector and the Agricultural Chemicals industry, with a classification confidence of 0.92.

AsiaPhos Ltd has a highly leveraged capital structure, with a debt-to-equity ratio of 1.64, indicating that the company is financed more by debt than equity. The company's liquidity position is medium, with a current ratio of 1.07, suggesting that it has just enough current assets to cover its current liabilities. The company's operating cash flow is negative at -236,000 SGD, and its free cash flow is also negative at -415,000 SGD, indicating that it is not generating sufficient cash from operations to fund its activities. In terms of profitability, AsiaPhos Ltd is currently unprofitable, with a net income of -447,000 SGD and an operating income of -409,000 SGD. The company's return on equity is -23.35%, and its return on assets is -1.56%, both of which are significantly below the industry median for Agricultural Chemicals. The company's gross profit of 50,000 SGD is also low relative to its revenue of 260,000 SGD, indicating that it is not effectively managing its production costs. AsiaPhos Ltd's revenue is not segmented by geographic region or product line in the available data, so it is not possible to assess the company's geographic exposure or revenue concentration. However, the company's operations are likely concentrated in the agricultural chemicals sector, which is subject to fluctuations in commodity prices and demand for agricultural products. The company's growth trajectory is currently negative, with a net income of -447,000 SGD and an operating income of -409,000 SGD. There is no indication of a positive revenue growth rate in the available data, and the company's capital expenditure is zero, suggesting that it is not investing in new projects or expansion. AsiaPhos Ltd faces several risk factors, including a high debt-to-equity ratio and negative operating and free cash flows. The company's liquidity risk is medium, and its net cash position is negative after subtracting total debt, which could limit its ability to meet short-term obligations. The company's dilution risk is low, and there is no indication of recent share issuance or dilution pressure. There are no recent events or filings mentioned in the available data that would indicate significant changes in the company's operations or financial position. The company's financial performance and risk profile suggest that it is currently facing significant challenges and may require restructuring or additional financing to improve its financial health.
Key takeaways
  • AsiaPhos Ltd is currently unprofitable, with a net income of -447,000 SGD and an operating income of -409,000 SGD.
  • The company has a high debt-to-equity ratio of 1.64, indicating a significant reliance on debt financing.
  • AsiaPhos Ltd's liquidity position is medium, with a current ratio of 1.07 and negative operating and free cash flows.
  • The company's return on equity is -23.35%, and its return on assets is -1.56%, both of which are significantly below the industry median.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencySGD
Revenue$260.0k
Gross profit$50.0k
Operating income-$409.0k
Net income-$447.0k
R&D
SG&A
D&A
SBC
Operating cash flow-$236.0k
CapEx$0.00
Free cash flow-$415.0k
Total assets$28.6M
Total liabilities$26.7M
Total equity$1.9M
Cash & equivalents
Long-term debt$3.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.6M-$4.4M-$66.0M-$4.0M
FY-3$2.4M-$1.5M-$1.6M-$1.3M
FY-2$1.7M-$4.1M$2.1M-$4.3M
FY-1$4.3M-$2.6M$1.2M-$2.6M
FY0$5.3M-$1.8M-$1.7M-$1.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$21.8M$3.4M
FY-3$17.8M$1.0M
FY-2$21.0M$2.3M
FY-1$4.6M$3.4M
FY0$2.5M$1.7M
PeriodOCFCapExFCFSBC
FY-4-$2.7M-$10.0k-$4.0M
FY-3-$3.3M-$32.0k-$1.3M
FY-2$170.0k-$175.0k-$4.3M
FY-1-$4.8M-$28.0k-$2.6M
FY0-$362.0k$0.00-$1.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$260.0k-$409.0k-$447.0k-$415.0k
FQ-6
FQ-5$1.4M$1.3M$1.3M$1.3M
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$28.6M$1.9M
FQ-6
FQ-5$6.1M$4.1M
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7-$236.0k$0.00-$415.0k
FQ-6
FQ-5-$3.4M$0.00$1.3M
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.9M
Net cash-$3.1M
Current ratio1.1
Debt/Equity1.6
ROA-1.6%
ROE-23.4%
Cash conversion53.0%
CapEx/Revenue0.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricASIPActivity
Op margin-157.3%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin-171.9%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin19.2%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue0.0%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity164.0%37.1% medp25 10.3% · p75 82.0%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 02:26 UTC#525809ab
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 09:50 UTCJob: 2e4c6de7